Biomarkers in Posttraumatic Stress Disorder: Overview and Implications for Future Research
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
PTSD can develop in the aftermath of traumatic incidents like combat, sexual abuse, or life threatening accidents. Unfortunately, there are still no biomarkers for this debilitating anxiety disorder in clinical use. Anyhow, there are numerous studies describing potential PTSD biomarkers, some of which might progress to the point of practical use in the future. Here, we outline and comment on some of the most prominent findings on potential imaging, psychological, endocrine, and molecular PTSD biomarkers and classify them into risk, disease, and therapy markers. Since for most of these potential PTSD markers a causal role in PTSD has been demonstrated or at least postulated, this review also gives an overview on the current state of research on PTSD pathobiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Combat Duty in Iraq and Afghanistan, Mental Health Problems, and Barriers to Care
Hoge, C. W., Castro, C. A., Messer, S. C., McGurk, D., Cotting, D. I., & Koffman, R. L. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040603 · Cited by 4,778
(2013) · The Lancet · doi:10.1016/s0140-6736(12)62129-1 · Cited by 3,010
Krishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., LaPlant, Q., Graham, A., Lutter, M., Lagace, D. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.018 · Cited by 2,307 · cited 1×
“Of high value is the distinction between responders and nonresponders in these models [77, 137, 138] which not only allow to test novel pharmacological compounds, but also to search for biomarkers of PTSD vulnerability versus resilience in rats and mice.”
BackgroundSmaller hippocampal volume predicts pathologic vulnerability to psychological trauma
Gilbertson, M. W., Shenton, M. E., Ciszewski, A., Kasai, K., Lasko, N. B., Orr, S. P., & Pitman, R. K. (2002) · Nature Neuroscience · doi:10.1038/nn958 · Cited by 1,635
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.7.973 · Cited by 1,610
Biological studies of post-traumatic stress disorder
Pitman, R. K., Rasmusson, A. M., Koenen, K. C., Shin, L. M., Orr, S. P., Gilbertson, M. W., Milad, M. R., & Liberzon, I. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3339 · Cited by 1,529
Allele-specific FKBP5 DNA demethylation mediates gene–childhood trauma interactions
Klengel, T., Mehta, D., Anacker, C., Rex-Haffner, M., Pruessner, J. C., Pariante, C. M., Pace, T. W. W., Mercer, K. B., Mayberg, H. S., Bradley, B., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3275 · Cited by 1,447 · cited 3×
“This demethylation was found to be linked to increased stress-dependent FKBP5 gene transcription associated with a long-term dysregulation of the stress hormone system and an elevated risk for developing stress-related psychiatric disorders like PTSD [22].”
BackgroundWhy stress is bad for your brain
Sapolsky, R. M. (1996) · Science · doi:10.1126/science.273.5276.749 · Cited by 1,306 · cited 1×
“Moreover, it was hypothesized that PTSD-associatedmemory deficits result from excessive cortisol blood levels which probably lead to atrophy of the hippocampus [87, 88], an area known to play a pivotal role in learning and memory [89].”
BackgroundPsychobiology and molecular genetics of resilience
Feder, A., Nestler, E. J., & Charney, D. S. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2649 · Cited by 1,272 · cited 1×
“Hence it might be similarly important to identify resilience markers [11, 14, 15], especially since resilience and vulnerability may represent extremes of the same dimension (e.”
BackgroundBinder, E. B., Salyakina, D., Lichtner, P., Wochnik, G. M., Ising, M., Pütz, B., Papiol, S., Seaman, S., Lucae, S., Kohli, M. A., et al. (2004) · Nature Genetics · doi:10.1038/ng1479 · Cited by 977 · cited 2×
“Besides PTSD, FKBP5 has also been reported as a putative biomarker in mood disorders like major depression [123–125] as well as a biomarker of nonpsychiatric disorders like cancer [126–128].”
BackgroundBinder, E. B. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.021 · Cited by 968
A meta-analysis of structural brain abnormalities in PTSD
KARL, A., SCHAEFER, M., MALTA, L., DORFEL, D., ROHLEDER, N., & WERNER, A. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.03.004 · Cited by 881 · cited 2×
“In PTSD patients, a volume reduction of the amygdala, the anterior cingulate cortex, the prefrontal cortex, and, most prominently, the hippocampus was described [91].”
BackgroundResultThe science of resilience: implications for the prevention and treatment of depression
Southwick, S. M., & Charney, D. S. (2012) · Science · doi:10.1126/science.1222942 · Cited by 875 · cited 1×
“Hence it might be similarly important to identify resilience markers [11, 14, 15], especially since resilience and vulnerability may represent extremes of the same dimension (e.”
BackgroundThe Epidemiology of Trauma, PTSD, and Other Posttrauma Disorders
Breslau, N. (2009) · Trauma, Violence, & Abuse · doi:10.1177/1524838009334448 · Cited by 810
Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor
Ressler, K. J., Mercer, K. B., Bradley, B., Jovanovic, T., Mahan, A., Kerley, K., Norrholm, S. D., Kilaru, V., Smith, A. K., Myers, A. J., et al. (2011) · Nature · doi:10.1038/nature09856 · Cited by 800
Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.5.624 · Cited by 721 · cited 2×
“Some studies detected elevated levels of corticotropin-releasing hormone (CRH) in cerebrospinal fluid (CSF) of PTSD patients [47, 48] and another study reported that CSF CRH concentrations declined during exposure to a trauma-related audiovisual stimulus [49].”
BackgroundTrue, W. R. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820160019002 · Cited by 704 · cited 1×
“Finally, heritability has been discussed as a PTSD vulnerability marker by some authors [38, 39].”
BackgroundPosttraumatic stress disorder and physical illness: results from clinical and epidemiologic studies
BOSCARINO, J. A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1314.011 · Cited by 691
Baker, D. G., West, S. A., Nicholson, W. E., Ekhator, N. N., Kasckow, J. W., Hill, K. K., Bruce, A. B., Orth, D. N., & Geracioti, T. D. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.4.585 · Cited by 531
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.1.83 · Cited by 517
Low urinary cortisol excretion in Holocaust survivors with posttraumatic stress disorder
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.7.982 · Cited by 499
Yehuda, R. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950190065010 · Cited by 449 · cited 1×
“Some of these trials demonstrate that PTSD patients exhibit elevated salivary cortisol levels in response to laboratory stressors [55–57] while others found an enhanced plasma cortisol suppression after application of low dose dexamethasone [10, 58, 59].”
BackgroundImpaired fear inhibition is a biomarker of PTSD but not depression
Jovanovic, T., Norrholm, S. D., Blanding, N. Q., Davis, M., Duncan, E., Bradley, B., & Ressler, K. J. (2010) · Depression and Anxiety · doi:10.1002/da.20663 · Cited by 444 · cited 1×
“Second, impaired fear inhibition assessed by fearpotentiated startle was found to be a biomarker of PTSD, but not of depression [134].”
BackgroundMollica, R. F., McInnes, K., Pool, C., & Tor, S. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.6.482 · Cited by 425
Kitayama, N., Vaccarino, V., Kutner, M., Weiss, P., & Bremner, J. D. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.05.014 · Cited by 423
Woon, F. L., & Hedges, D. W. (2008) · Hippocampus · doi:10.1002/hipo.20437 · Cited by 416
Woon, F. L., Sood, S., & Hedges, D. W. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.016 · Cited by 410
Smith, M. E. (2005) · Hippocampus · doi:10.1002/hipo.20102 · Cited by 395 · cited 1×
“In addition, reports on PTSD-associated lateralization of hippocampal volume loss are also controversial: while one meta-analysis reports such lateralization effects [98], others found none [99, 100].”
ResultPharmacologic alternatives to antidepressants in posttraumatic stress disorder: A systematic review
Berger, W., Mendlowicz, M. V., Marques-Portella, C., Kinrys, G., Fontenelle, L. F., Marmar, C. R., & Figueira, I. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.12.004 · Cited by 347 · cited 1×
“However, treatment results are disappointing since only 20–30% of SSRI-treated PTSD patients reach full remission [13].”
BackgroundHigher cortisol levels following exposure to traumatic reminders in abuse-related PTSD
Elzinga, B. M., Schmahl, C. G., Vermetten, E., van Dyck, R., & Bremner, J. D. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300226 · Cited by 341
Bryant, R. A., Felmingham, K., Kemp, A., Das, P., Hughes, G., Peduto, A., & Williams, L. (2008) · Psychological Medicine · doi:10.1017/s0033291707002231 · Cited by 307
Yehuda, R., Cai, G., Golier, J. A., Sarapas, C., Galea, S., Ising, M., Rein, T., Schmeidler, J., Müller-Myhsok, B., Holsboer, F., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.02.034 · Cited by 294 · cited 2×
“In a small study comparing individuals with and without PTSD in a group of Caucasians who all had been exposed to the 9/11 attack on New York City, several genes involved in glucocorticoid signaling were differentially expressed among individuals with current PTSD: mRNA levels of FKBP5 and the GR-inhibitor STAT5B were…”
BackgroundNeuroendocrine and Psychophysiologic Responses in PTSD: A Symptom Provocation Study
Liberzon, I. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00128-6 · Cited by 292 · cited 2×
“[57] I.”
BackgroundLekman, M., Laje, G., Charney, D., Rush, A. J., Wilson, A. F., Sorant, A. J. M., Lipsky, R., Wisniewski, S. R., Manji, H., McMahon, F. J., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.10.026 · Cited by 284
Fennema-Notestine, C., Stein, M. B., Kennedy, C. M., Archibald, S. L., & Jernigan, T. L. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01413-0 · Cited by 274 · cited 2×
“However, whereas some studies report a decreased hippocampal volume in PTSD patients [92–94] other studies did not replicate these findings [95–97].”
ResultGray Matter Correlates of Posttraumatic Stress Disorder: A Quantitative Meta-Analysis
Kühn, S., & Gallinat, J. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.029 · Cited by 259
SCHMAND, B., SMIT, J. H., GEERLINGS, M. I., & LINDEBOOM, J. (1997) · Psychological Medicine · doi:10.1017/s0033291797005461 · Cited by 258 · cited 2×
“[30] B.”
BackgroundDecreased hippocampal N-acetylaspartate in the absence of atrophy in posttraumatic stress disorder
Schuff, N., Neylan, T. C., Lenoci, M. A., Du, A.-T., Weiss, D. S., Marmar, C. R., & Weiner, M. W. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01245-8 · Cited by 237
Grillon, C., Morgan, C. A., Southwick, S. M., Davis, M., & Charney, D. S. (1996) · Psychiatry Research · doi:10.1016/s0165-1781(96)02942-3 · Cited by 221
Sartor, C. E. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1385 · Cited by 212 · cited 1×
“In fact, a recent twin study found that heritable influences accounted for 46% of the variance in PTSD [40].”
BackgroundPTSD and stress sensitisation: A tale of brain and body
Stam, R. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.11.010 · Cited by 211
PTSD symptoms and cognitive performance in recent trauma survivors
Brandes, D., Ben-Schachar, G., Gilboa, A., Bonne, O., Freedman, S., & Shalev, A. Y. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00125-7 · Cited by 205 · cited 2×
“A number of studies report cognitive impairments in PTSD patients which become apparent in alterations in learning and memory [83–85].”
BackgroundMaes, M., Lin, A., Bonacccorso, S., Van Hunsel, F., GASTEL, A. V., Delmeire, L., Biondi, M., Bosmans, E., Kenis, G., & Scharpé, S. (1998) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1998.tb10092.x · Cited by 204
van Zuiden, M., Geuze, E., Willemen, H. L. D. M., Vermetten, E., Maas, M., Amarouchi, K., Kavelaars, A., & Heijnen, C. J. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.026 · Cited by 201 · cited 1×
“Moreover, low mRNA levels of the GR-inhibitor FK506 binding protein 5 (FKBP51) and high glucocorticoid-induced leucine zipper (GILZ) mRNA expression levels were independently associated with an increased risk for a high expression of postdeployment PTSD symptoms [18].”
BackgroundMehta, D. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.50 · Cited by 200 · cited 1×
“[65].”
van Zuiden, M., Geuze, E., Willemen, H. L. D. M., Vermetten, E., Maas, M., Heijnen, C. J., & Kavelaars, A. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10050706 · Cited by 190 · cited 1×
“Their analyses revealed that an elevated sensitivity of leukocytes for glucocorticoids and a high number of glucocorticoid receptors (GR) in peripheral blood monocytes prior to deployment predicted PTSD development [16, 17].”
BackgroundGilbertson, M. W., Paulus, L. A., Williston, S. K., Gurvits, T. V., Lasko, N. B., Pitman, R. K., & Orr, S. P. (2006) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.115.3.484 · Cited by 186 · cited 2×
“[29] M.”
BackgroundFrodl, T., Carballedo, A., Hughes, M. M., Saleh, K., Fagan, A., Skokauskas, N., McLoughlin, D. M., Meaney, J., O'Keane, V, & Connor, T. J. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.14 · Cited by 176
Does PTSD Impair Cognition Beyond the Effect of Trauma?
Qureshi, S. U., Long, M. E., Bradshaw, M. R., Pyne, J. M., Magruder, K. M., Kimbrell, T., Hudson, T. J., Jawaid, A., Schulz, P. E., & Kunik, M. E. (2011) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.23.1.16 · Cited by 170 · cited 2×
“That choosing between these two types of controls matters is inter alia shown by the review of Qureshi and colleagues who reported that the strength of the association of PTSD with cognitive impairment varied significantly with the control groups included in statistical analysis [90].”
BackgroundPole, N., Neylan, T. C., Otte, C., Henn-Hasse, C., Metzler, T. J., & Marmar, C. R. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.07.015 · Cited by 164
van Liempt, S., van Zuiden, M., Westenberg, H., Super, A., & Vermetten, E. (2013) · Depression and Anxiety · doi:10.1002/da.22054 · Cited by 163 · cited 1×
“For instance, in Dutch combat soldiers, predeployment nightmares were found to be associated with elevated PTSD susceptibility [26].”
BackgroundVerbal memory and treatment response in post-traumatic stress disorder
Wild, J., & Gur, R. C. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.045922 · Cited by 127 · cited 1×
“Besides molecular and imaging PTSD therapy stratification/prediction markers, performance of verbal memory and mixed-handedness were postulated to be suitable as putative PTSD treatment response markers [118, 119].”
MethodGeracioti, T. D., Baker, D. G., Kasckow, J. W., Strawn, J. R., Jeffrey Mulchahey, J., Dashevsky, B. A., Horn, P. S., & Ekhator, N. N. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.12.012 · Cited by 103
van Zuiden, M., Heijnen, C. J., Maas, M., Amarouchi, K., Vermetten, E., Geuze, E., & Kavelaars, A. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.03.018 · Cited by 91
Physiologic responses to loud tones in israeli veterans of the 1973 yom kippur war
Orr, S. P., Solomon, Z., Peri, T., Pitman, R. K., & Shalev, A. Y. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(95)00671-0 · Cited by 88
Koenen, K. C., Lyons, M. J., Goldberg, J., Simpson, J., Williams, W. M., Toomey, R., Eisen, S. A., True, W., & Tsuang, M. T. (2003) · Journal of Traumatic Stress · doi:10.1023/a:1025786925483 · Cited by 88 · cited 1×
“Finally, heritability has been discussed as a PTSD vulnerability marker by some authors [38, 39].”
BackgroundImplications of Hypothalamic–Pituitary–Adrenal Axis Functioning in Posttraumatic Stress Disorder
Jones, T., & Moller, M. D. (2011) · Journal of the American Psychiatric Nurses Association · doi:10.1177/1078390311420564 · Cited by 67
Cited by
Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values
Dhama, K., Latheef, S. K., Dadar, M., Samad, H. A., Munjal, A., Khandia, R., Karthik, K., Tiwari, R., Yatoo, M. I., Bhatt, P., et al. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00091 · Cited by 321
Michopoulos, V., Norrholm, S. D., & Jovanovic, T. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.01.005 · Cited by 206
Schubert, C. F., Schmidt, U., & Rosner, R. (2016) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.1985 · Cited by 127
Self-citationAn epigenome-wide DNA methylation study of PTSD and depression in World Trade Center responders
Kuan, P.-F., Waszczuk, M. A., Kotov, R., Marsit, C. J., Guffanti, G., Gonzalez, A., Yang, X., Koenen, K., Bromet, E., & Luft, B. J. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.130 · Cited by 103
Zaba, M., Kirmeier, T., Ionescu, I. A., Wollweber, B., Buell, D. R., Gall-Kleebach, D. J., Schubert, C. F., Novak, B., Huber, C., Köhler, K., et al. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.02.005 · Cited by 101
Self-citation
Metadata
- Authors
- Schmidt, U., Kaltwasser, S. F., & Wotjak, C. T.
- Venue
- Disease Markers
- Publisher
- Hindawi Limited
- Published
- 2013
- Volume
- 35
- Issue
- 1
- Pages
- 43-54
- ISSN
- 0278-0240 (ISSN-L)
- 1875-8630
- OpenAlex
- W2000592388
- Cited by
- 103
- References
- 57
- FWCI
- 11.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.